AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIODESIX INC Director's Dealing 2020

Oct 28, 2020

34472_dirs_2020-10-27_65af3843-8dfa-469d-8165-821f9f8257f9.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: BIODESIX INC (BDSX)
CIK: 0001439725
Period of Report: 2020-10-27

Reporting Person: Hutton Scott (Director, President & CEO)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Ownership
Stock Options (Right to buy)	$0.42	2028-04-03	Common Stock (84233)	Direct
Stock Options (Right to buy)	$0.78	2028-12-31	Common Stock (42116)	Direct
Stock Options (Right to buy)	$0.78	2030-04-14	Common Stock (151619)	Direct

Footnotes

F1: This option vested 40% on March 1, 2020, and the remaining 60% in 36 successive, equal monthly installments measured from March 1, 2020.

F2: This option vests twenty-one sixtieths (21/60ths) on October 1, 2020, the remaining balance vests in 39 successive, equal monthly installments measured from October 1, 2020.

F3: This option vests in 60 successive, equal monthly installments measured from January 1, 2020.